The transcription factor C/EBPα is required for granulocytic differentiation of normal myeloid progenitors and is frequently inactivated in acute myeloid leukemia (AML) cells. Ectopic expression of C/EBPα in AML cells suppresses proliferation and induces differentiation suggesting that restoring C/EBPα expression/activity in AML cells could be therapeutically useful. Unfortunately, current approaches of gene or protein delivery in leukemic cells are unsatisfactory. However, "drug repurposing" is becoming a very attractive strategy to identify potential new uses for existing drugs. In this study, we assessed the biological effects of candidate C/EBPα-mimetics identified by interrogation of the Connectivity Map database. We found that amantadine, an antiviral and anti-Parkinson agent, induced a monocyte-macrophage-like differentiation of HL60, U937, Kasumi-1 myeloid leukemia cell lines, as indicated by morphology and differentiation antigen expression, when used in combination with suboptimal concentration of all trans retinoic acid (ATRA) or Vit D3. The effect of amantadine depends, in part, on increased activity of the vitamin D receptor (VDR), since it induced VDR expression and amantadine-dependent monocyte-macrophage differentiation of HL60 cells was blocked by expression of dominant-negative VDR. These results reveal a new function for amantadine and support the concept that screening of the Connectivity Map database can identify small molecules that mimic the effect of transcription factors required for myelo-monocytic differentiation.

Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database / Manzotti, Gloria; Parenti, Sandra; Ferrari, Giovanna; Soliera, Angela Rachele; Cattelani, Sara; Montanari, Monica; Grande, Alexis; Calabretta, Bruno; Ertel, Adam; Cavalli, Daniel. - In: CELL CYCLE. - ISSN 1538-4101. - 14:16(2015), pp. 2578-2589. [10.1080/15384101.2015.1033591]

Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database

MANZOTTI, GLORIA;PARENTI, Sandra;FERRARI, Giovanna;SOLIERA, Angela Rachele;CATTELANI, Sara;MONTANARI, Monica;GRANDE, Alexis;CALABRETTA, Bruno;
2015

Abstract

The transcription factor C/EBPα is required for granulocytic differentiation of normal myeloid progenitors and is frequently inactivated in acute myeloid leukemia (AML) cells. Ectopic expression of C/EBPα in AML cells suppresses proliferation and induces differentiation suggesting that restoring C/EBPα expression/activity in AML cells could be therapeutically useful. Unfortunately, current approaches of gene or protein delivery in leukemic cells are unsatisfactory. However, "drug repurposing" is becoming a very attractive strategy to identify potential new uses for existing drugs. In this study, we assessed the biological effects of candidate C/EBPα-mimetics identified by interrogation of the Connectivity Map database. We found that amantadine, an antiviral and anti-Parkinson agent, induced a monocyte-macrophage-like differentiation of HL60, U937, Kasumi-1 myeloid leukemia cell lines, as indicated by morphology and differentiation antigen expression, when used in combination with suboptimal concentration of all trans retinoic acid (ATRA) or Vit D3. The effect of amantadine depends, in part, on increased activity of the vitamin D receptor (VDR), since it induced VDR expression and amantadine-dependent monocyte-macrophage differentiation of HL60 cells was blocked by expression of dominant-negative VDR. These results reveal a new function for amantadine and support the concept that screening of the Connectivity Map database can identify small molecules that mimic the effect of transcription factors required for myelo-monocytic differentiation.
23-giu-2015
14
16
2578
2589
Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database / Manzotti, Gloria; Parenti, Sandra; Ferrari, Giovanna; Soliera, Angela Rachele; Cattelani, Sara; Montanari, Monica; Grande, Alexis; Calabretta, Bruno; Ertel, Adam; Cavalli, Daniel. - In: CELL CYCLE. - ISSN 1538-4101. - 14:16(2015), pp. 2578-2589. [10.1080/15384101.2015.1033591]
Manzotti, Gloria; Parenti, Sandra; Ferrari, Giovanna; Soliera, Angela Rachele; Cattelani, Sara; Montanari, Monica; Grande, Alexis; Calabretta, Bruno; Ertel, Adam; Cavalli, Daniel
File in questo prodotto:
File Dimensione Formato  
Amantadina cell cycle.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 723.1 kB
Formato Adobe PDF
723.1 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1078649
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact